Dataset related to: "Are Extracorporeal Shock Waves Just a Therapeutic Tool?"

<p>We provide the raw data used for the following article:</p> <p>Gialanella B, Comini L, Bonometti GP, Vanoglio F, Bettinsoli A, Santoro R, Olivares A, Luisa A. <strong>Are Extracorporeal Shock Waves Just a Therapeutic Tool?</strong>&nbsp;Diagnostics 2024, 14, 2440. https://doi.org/10.3390/diagnostics14212440.&nbsp;</p> <p>Abstract: Background: Focused extracorporeal shock wave therapy (ESWT) has been successfully<br>used to treat musculoskeletal conditions, but ESWT stimulates nociceptors, causing pain deep in<br>the tissue during treatment. The occurrence of pain during ESWT is a side effect, but it can help<br>identify painful sites and assess minimum (MiTI) and maximum (MaTI) pain thresholds to ESWT<br>pressure stimuli. This topic has received limited attention in literature. Methods: This observational<br>study describes a specific approach to using ESWT to study pain in 71 patients. The approach<br>proposes moving the ESWT transducer head of the device over the entire joint surface, progressively<br>increasing the energy level until the patient experiences pain. Results: In the study, MiTI and<br>MaTI were 0.218 &plusmn; 0.090 and 0.416 &plusmn; 0.165 mJ/mm2 in the affected joint and 0.282 &plusmn; 0.128 and<br>0.501 &plusmn; 0.174 mJ/mm2 in the contralateral homologous healthy joint, being significantly lower in the<br>affected joint (MiTI: p &lt; 0.001 and MaTI: p = 0.003, respectively). ESWT induced pain in 94.37% of<br>the sites with the highest subjective pain and in a greater number of sites (204) than digital pressure<br>(123) (p &lt; 0.001). All sites with digital pressure pain also had ESWT pain. Conclusions: These results<br>suggest that the ESWT device may be useful in investigating pain in musculoskeletal conditions and<br>tailoring therapy.</p>